Search

everythinglearnresearchcommunity

for

Search:↓

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Male hypogonadism affects skin and hair, causing thin skin, less hair, and skin reactions to treatment.

Testosterone therapy significantly improved Hidradenitis Suppurativa symptoms.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

3βHSD2 is not useful for diagnosing PCOS.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Hormone levels in women with androgenetic alopecia are similar to those without the condition.

Hair loss in women linked to higher sexual dysfunction risk.

HS needs personalized treatment plans and more research.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Surgery improved symptoms and normalized hormone levels in a woman with an adrenal tumor.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Hidradenitis suppurativa improves with antiandrogen therapy.

Dermatologists should address erectile dysfunction in patients with skin conditions to improve their quality of life.

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.